Please enable JavaScript to continue using this application.

Compare $ERAS vs $ORKA | Chartloom

Compare

$ERAS vs $ORKA

Erasca Inc · Oruka Therapeutics Inc

ERAS

Erasca Inc

ORKA

Oruka Therapeutics Inc

Compare $ERAS vs $ORKA

Comparing Erasca Inc and Oruka Therapeutics Inc

ERASErasca Inc

ORKAOruka Therapeutics Inc

ERASErasca Inc

Market cap

$5.49B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

346.5%

52W performance

559.7%

FCF yield

-1.8%

ORKAOruka Therapeutics Inc

Market cap

$4.95B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

190.4%

52W performance

263.0%

FCF yield

-2.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ERAS

ORKA

Detailed metrics comparison

ERAS

Erasca Inc

ORKA

Oruka Therapeutics Inc

Market Cap

ERAS$5.49B

ORKA$4.95B

Enterprise Value

ERAS$5.44B

ORKA$4.68B

Price

ERAS$16.03

ORKA$82.11

P/E Ratio

ERASN/A

ORKAN/A

P/S Ratio

ERAS0.00x

ORKA119.42x

EV/Sales

ERAS0.00x

ORKA113.69x

EV/EBITDA

ERAS0.00x

ORKA0.00x

P/B Ratio

ERAS14.25x

ORKA5.02x

P/FCF Ratio

ERASN/A

ORKAN/A

EV/FCF

ERAS-55.50x

ORKA-46.30x

PEG Ratio

ERASN/A

ORKAN/A

Forward P/E (NTM)

ERASN/A

ORKAN/A

Forward P/S (NTM)

ERASN/A

ORKAN/A

Revenue (TTM)

ERAS$0

ORKA$0

Revenue Growth (YoY)

ERASN/A

ORKAN/A

Forward Rev Growth

ERAS959.7%

ORKA679.2%

Gross Margin (TTM)

ERAS0.0%

ORKA0.0%

Operating Margin (TTM)

ERAS0.0%

ORKA0.0%

EBITDA Margin (TTM)

ERAS0.0%

ORKA0.0%

Net Margin (TTM)

ERAS0.0%

ORKA0.0%

FCF Margin (TTM)

ERASN/A

ORKAN/A

Net Income (TTM)

ERAS$-287M

ORKA$-133M

FCF (TTM)

ERAS$-98M

ORKA$-101M

EPS (TTM)

ERAS-$0.92

ORKA-$2.11

ROE (TTM)

ERAS-8043.0%

ORKA-2076.0%

ROA (TTM)

ERAS-6708.0%

ORKA-2012.0%

ROIC (TTM)

ERAS-8043.0%

ORKA-2076.0%

Cash

ERAS$43M

ORKA$268M

Debt

ERAS$0

ORKA$0

Net Cash/Debt

ERAS$43M

ORKA$268M

Current Ratio (TTM)

ERAS8.29x

ORKA38.51x

Quick Ratio (TTM)

ERAS8.08x

ORKA38.03x

Debt/Equity (TTM)

ERAS0.00x

ORKA0.00x

Debt/Assets (TTM)

ERAS0.0%

ORKA0.0%

Interest Coverage (TTM)

ERASN/A

ORKAN/A

Net Debt/EBITDA (TTM)

ERAS0.00x

ORKA0.00x

Beta

ERAS0.67

ORKA-0.40

52W Performance

ERAS559.7%

ORKA263.0%

YTD Performance

ERAS346.5%

ORKA190.4%

% from 52W High

ERAS-34.0%

ORKA-28.9%

% from 52W Low

ERAS661.5%

ORKA279.1%

Asset Turnover (TTM)

ERAS0.00x

ORKA0.33x

FCF Yield (TTM)

ERAS-1.8%

ORKA-2.0%

Earnings Yield (TTM)

ERAS-5.2%

ORKA-2.7%

Dividend Yield (TTM)

ERASN/A

ORKAN/A

Rule of 40

ERAS0.0

ORKA0.0

EV/GP/RG

ERASN/A

ORKAN/A

Ticker research

View ERAS research View ORKA research

Metric	ERAS Erasca Inc	ORKA Oruka Therapeutics Inc
Market & Valuation
Market Cap	$5.49B	$4.95B
Enterprise Value	$5.44B	$4.68B
Price	$16.03	$82.11
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	119.42x
EV/Sales	0.00x	113.69x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.25x	5.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-55.50x	-46.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	959.7%	679.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-287M	$-133M
FCF (TTM)	$-98M	$-101M
EPS (TTM)	-$0.92	-$2.11
ROE (TTM)	-8043.0%	-2076.0%
ROA (TTM)	-6708.0%	-2012.0%
ROIC (TTM)	-8043.0%	-2076.0%
Financial Health
Cash	$43M	$268M
Debt	$0	$0
Net Cash/Debt	$43M	$268M
Current Ratio (TTM)	8.29x	38.51x
Quick Ratio (TTM)	8.08x	38.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.67	-0.40
52W Performance	559.7%	263.0%
YTD Performance	346.5%	190.4%
% from 52W High	-34.0%	-28.9%
% from 52W Low	661.5%	279.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.33x
FCF Yield (TTM)	-1.8%	-2.0%
Earnings Yield (TTM)	-5.2%	-2.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ERAS research	View ORKA research

Valuation

P/S Ratio

ERAS

0.00x

ORKA

119.42x

EV/FCF

ERAS

-55.50x

ORKA

-46.30x

Growth & revenue

Forward Revenue Growth

ERAS

959.7%

ORKA

679.2%

Profitability & performance

Gross Margin

ERAS

0.0%

ORKA

0.0%

ROE

ORKA

-2076.0%

ERAS

-8043.0%

FCF Yield %

ERAS

-1.8%

ORKA

-2.0%

52-Week Performance

ERAS

559.7%

ORKA

263.0%

Detailed metrics comparison

ERAS

Erasca Inc

ORKA

Oruka Therapeutics Inc

Market Cap

ERAS$5.49B

ORKA$4.95B

Enterprise Value

ERAS$5.44B

ORKA$4.68B

Price

ERAS$16.03

ORKA$82.11

P/E Ratio

ERASN/A

ORKAN/A

P/S Ratio

ERAS0.00x

ORKA119.42x

EV/Sales

ERAS0.00x

ORKA113.69x

EV/EBITDA

ERAS0.00x

ORKA0.00x

P/B Ratio

ERAS14.25x

ORKA5.02x

P/FCF Ratio

ERASN/A

ORKAN/A

EV/FCF

ERAS-55.50x

ORKA-46.30x

PEG Ratio

ERASN/A

ORKAN/A

Forward P/E (NTM)

ERASN/A

ORKAN/A

Forward P/S (NTM)

ERASN/A

ORKAN/A

Revenue (TTM)

ERAS$0

ORKA$0

Revenue Growth (YoY)

ERASN/A

ORKAN/A

Forward Rev Growth

ERAS959.7%

ORKA679.2%

Gross Margin (TTM)

ERAS0.0%

ORKA0.0%

Operating Margin (TTM)

ERAS0.0%

ORKA0.0%

EBITDA Margin (TTM)

ERAS0.0%

ORKA0.0%

Net Margin (TTM)

ERAS0.0%

ORKA0.0%

FCF Margin (TTM)

ERASN/A

ORKAN/A

Net Income (TTM)

ERAS$-287M

ORKA$-133M

FCF (TTM)

ERAS$-98M

ORKA$-101M

EPS (TTM)

ERAS-$0.92

ORKA-$2.11

ROE (TTM)

ERAS-8043.0%

ORKA-2076.0%

ROA (TTM)

ERAS-6708.0%

ORKA-2012.0%

ROIC (TTM)

ERAS-8043.0%

ORKA-2076.0%

Cash

ERAS$43M

ORKA$268M

Debt

ERAS$0

ORKA$0

Net Cash/Debt

ERAS$43M

ORKA$268M

Current Ratio (TTM)

ERAS8.29x

ORKA38.51x

Quick Ratio (TTM)

ERAS8.08x

ORKA38.03x

Debt/Equity (TTM)

ERAS0.00x

ORKA0.00x

Debt/Assets (TTM)

ERAS0.0%

ORKA0.0%

Interest Coverage (TTM)

ERASN/A

ORKAN/A

Net Debt/EBITDA (TTM)

ERAS0.00x

ORKA0.00x

Beta

ERAS0.67

ORKA-0.40

52W Performance

ERAS559.7%

ORKA263.0%

YTD Performance

ERAS346.5%

ORKA190.4%

% from 52W High

ERAS-34.0%

ORKA-28.9%

% from 52W Low

ERAS661.5%

ORKA279.1%

Asset Turnover (TTM)

ERAS0.00x

ORKA0.33x

FCF Yield (TTM)

ERAS-1.8%

ORKA-2.0%

Earnings Yield (TTM)

ERAS-5.2%

ORKA-2.7%

Dividend Yield (TTM)

ERASN/A

ORKAN/A

Rule of 40

ERAS0.0

ORKA0.0

EV/GP/RG

ERASN/A

ORKAN/A

Ticker research

View ERAS research View ORKA research

Metric	ERAS Erasca Inc	ORKA Oruka Therapeutics Inc
Market & Valuation
Market Cap	$5.49B	$4.95B
Enterprise Value	$5.44B	$4.68B
Price	$16.03	$82.11
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	119.42x
EV/Sales	0.00x	113.69x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.25x	5.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-55.50x	-46.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	959.7%	679.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-287M	$-133M
FCF (TTM)	$-98M	$-101M
EPS (TTM)	-$0.92	-$2.11
ROE (TTM)	-8043.0%	-2076.0%
ROA (TTM)	-6708.0%	-2012.0%
ROIC (TTM)	-8043.0%	-2076.0%
Financial Health
Cash	$43M	$268M
Debt	$0	$0
Net Cash/Debt	$43M	$268M
Current Ratio (TTM)	8.29x	38.51x
Quick Ratio (TTM)	8.08x	38.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.67	-0.40
52W Performance	559.7%	263.0%
YTD Performance	346.5%	190.4%
% from 52W High	-34.0%	-28.9%
% from 52W Low	661.5%	279.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.33x
FCF Yield (TTM)	-1.8%	-2.0%
Earnings Yield (TTM)	-5.2%	-2.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ERAS research	View ORKA research